• EpiEndo IR

EpiEndo Pharmaceuticals is granted EU Horizon 2020 award

EpiEndo Pharmaceuticals are proud to announce that we have been granted a Horizon 2020 grant from the European Union (EU) for the feasibility of the development of our compounds.

Horizon 2020 is a funding programme that was created by the EU to support and foster research in the European Research Area (ERA) with a budget of nearly 80bn EUR and will run until the year 2020. Collaborating in the Horizon 2020 programme raises the profile of grant recipients, as well as their expertise and facilities across new networks and partners.

72 views0 comments